DHX Company Co., Ltd. (031860.KQ)
KOSDAQ · KRW · Healthcare · Diagnostics & Research
₩693 (+0.00%) as of
Key statistics
- Market cap
- 1.87B
- Dividend yield
- 0.00%
- 52-week range
- 202.00 – 6,930.00
- Beta
- -0.31
- Revenue (TTM)
- 13.66B
- Profit margin
- -205.49%
About DHX Company Co., Ltd.
DHX Company Co., Ltd. engages in biomedical and distribution businesses in South Korea. The company offers Microbiome to treat intractable skin diseases; REJURUB; and AI digital brain diagnostic device. It also purchases and distributes IT components, including graphics cards, DRAM, CPUs, high-capacity storage, and multi-purpose displays; import and distribution of cosmetics; f and b distribution; and meditech distribution. In addition, the company is involved in manufacture and distribution of computers and peripherals; investment and asset management; and commodity brokerage business. The company was formerly known as SU-Holdings Co.,Ltd. and changed its name to DHX Company Co., Ltd. in December 2024. DHX Company Co., Ltd. was founded in 1979 and is headquartered in Seoul, South Korea.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Seoul, South Korea
- Employees
- 27
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.